DISCOVERY OF A FIRST-IN-CLASS MPP8 ANTAGONIST TO REVERSE LINEAGE PLASTICITY IN TREATMENT- RESISTANT PROSTATE CANCER.
$933,000FY2021Defense Health AgencyDOD
University Of North Carolina At Chapel Hill, Chapel Hill NC
University Of North Carolina At Chapel Hill, Chapel Hill NC